sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> parkinsons disease therapeutics market

report

Parkinson’s Disease Therapeutics Market, by Treatment Types (Medical Devices (Deep Brain Stimulation Devices, Carbidopa/Levodopa Enteral Suspension Delivery Devices), Medications (Dopamine Precursors, Peripheral Decarboxylase Inhibitors, COMT Inhibitors, MAO Inhibitors)), End-users (Hospitals, Clinics, Homecare Settings) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC241 January 2017 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the Parkinson's disease therapeutics market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Parkinson's disease therapeutics market. The scope of this report covers the Parkinson's disease therapeutics market by its major segments, which include the treatment types, end-users, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Advancements in Parkinson’s disease therapeutics, increasing approvals for the neurostimulation devices, and gene therapies are expected to boost the growth of the Parkinson's disease therapeutics market during the forecast period.
  • The factors such as rising prevalence of Parkinson’s disease and the growing geriatric population are anticipated to increase the demand for the Parkinson's diseases therapeutics market.
  • However, patent expirations of the blockbuster drugs such as Azilect are expected to hinder the growth of the Parkinson's disease therapeutics market during the forecast period.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s Parkinson's disease therapeutics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the Parkinson's disease therapeutics market by the following segments:

  • Parkinson's Disease Therapeutics Market, by Treatment Type
    • Medical Devices
      • Deep Brain Stimulation Devices
      • Carbidopa / Levodopa Enteral Suspension Delivery Devices
    • Medications
      • Dopamine Precursors
      • Peripheral Decarboxylase Inhibitors
      • COMT Inhibitors
      • MAO Inhibitors
  • Parkinson's Disease Therapeutics Market, by End-Users
    • Hospitals
    • Clinics
    • Homecare Settings

KEY MARKET PLAYERS

Key players in the Parkinson's disease therapeutics market include:

  • Salix Pharmaceuticals
  • GlaxoSmithKline Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Cipla Inc.
  • mpax Laboratories, Inc.
  • Orion Corporation.
  • Daiichi Sankyo.
  • Mylan N.V.
  • Par Pharmaceutical.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Parkinsons Disease Therapeutics Market

TRENDING RELATED REPORT


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Analysis
    3. Ecosystem Analysis
  5. PARKINSON'S DISEASE THERAPEUTICS MARKET, BY TREATMENT TYPE
    1. Segment Share
    2. Treatment Type
      1. Medical Devices
        1. Deep Brain Stimulation Devices
        2. Carbidopa / Levodopa Enteral Suspension Delivery Devices
      2. Medications
        1. Dopamine Precursors
        2. Peripheral Decarboxylase Inhibitors
        3. COMT Inhibitors
        4. MAO Inhibitors
  6. PARKINSON'S DISEASE THERAPEUTICS MARKET, BY END-USERS
    1. Segment Share
    2. End-users
      1. Hospitals
      2. Clinics
      3. Homecare Settings
  7. PARKINSON'S DISEASE THERAPEUTICS MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Treatment Type
      3. By End-users
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Treatment Type
      3. By End-users
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Treatment Type
      3. By End-users
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East and Africa
      2. By Treatment Type
      3. By End-users
  8. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2015
    2. Key Innovators
  9. KEY MARKET PLAYERS
    1. Salix Pharmaceuticals
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. GlaxoSmithKline Plc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Teva Pharmaceutical Industries Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Cipla Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. mpax Laboratories, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Orion Corporation.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Daiichi Sankyo.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Mylan N.V.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Par Pharmaceutical.
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us